Pet Pharmaceuticals Market

Pet pharmaceutical refers specifically to medicines given to pets.

In terms of the purpose of use, pet drugs are mainly used by dogs and cats. Through drug prevention and treatment of pet diseases, the cure rate of pet diseases can be improved, the physical and mental health of pets can be guaranteed, and the quality of life of pets can be improved.

In terms of clinical significance, the application of pet drugs can provide clinical data for the research and development of new pet drugs, and promote the replacement and upgrading of new pet drugs.

Pet Pharmaceuticals Market contains market size and forecasts of Pet Pharmaceuticals in global, including the following market information:

Global Pet Pharmaceuticals Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Pet Pharmaceuticals Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Pet Pharmaceuticals companies in 2021 (%)

The global Pet Pharmaceuticals market was valued at 14680 million in 2021 and is projected to reach US$ 23120 million by 2028, at a CAGR of 6.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Antiparasitic Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Pet Pharmaceuticals include Zoetis, Boehringer Ingelheim, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol and Ouro Fino Saude, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Pet Pharmaceuticals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Pet Pharmaceuticals Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Pet Pharmaceuticals Market Segment Percentages, by Type, 2021 (%)

Antiparasitic

Biological Products

Antibacterial

Others

Global Pet Pharmaceuticals Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Pet Pharmaceuticals Market Segment Percentages, by Application, 2021 (%)

Prevention

Treatment

Global Pet Pharmaceuticals Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Pet Pharmaceuticals Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Pet Pharmaceuticals revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Pet Pharmaceuticals revenues share in global market, 2021 (%)

Key companies Pet Pharmaceuticals sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Pet Pharmaceuticals sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Zoetis

Boehringer Ingelheim

Merck

Elanco

Virbac

Dechra Veterinary Products

Ceva

Vetoquinol

Ouro Fino Saude

Norbrook

Jindun

Chopperlvya Animal Health

CAHIC